Impact of measurable residual disease by decentralized flow cytometry: a PETHEMA real-world study in 1076 patients with acute myeloid leukemia.
Leukemia
; 35(8): 2358-2370, 2021 08.
Article
in En
| MEDLINE
| ID: mdl-33526859
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Leukemia, Myeloid, Acute
/
Antineoplastic Combined Chemotherapy Protocols
/
Neoplasm, Residual
/
Hematopoietic Stem Cell Transplantation
/
Induction Chemotherapy
/
Flow Cytometry
/
Neoplasm Recurrence, Local
Type of study:
Observational_studies
/
Prognostic_studies
/
Risk_factors_studies
Aspects:
Patient_preference
Limits:
Aged
/
Female
/
Humans
/
Male
/
Middle aged
Language:
En
Journal:
Leukemia
Year:
2021
Document type:
Article